Welcome to our dedicated page for Restart Life news (Ticker: NMLSD), a resource for investors and traders seeking the latest updates and insights on Restart Life stock.
The NMLSD news page on Stock Titan tracks news releases and corporate updates for Restart Life Sciences Corp., a Canadian-based life sciences company. Restart Life Sciences is listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange, with NMLSD representing its trading on the OTC Pink market in the United States.
Company news has highlighted Restart Life Sciences’ focus on health-related products, brand development, and intellectual property. Recent disclosures describe an exclusive trademark licensing agreement covering four health-related trademarks, including a health-care-related brand that previously generated revenue through sales of health-related products on Amazon. The company presents this agreement as a way to support future brand development and expand its product portfolio.
News items also cover operational partnerships, such as a joint venture with Brain Balls Inc. to develop health-focused products aimed at cognitive performance, mental clarity, and overall brain health. In connection with this joint venture, Restart Life Sciences has announced a strategic production partnership with a Canadian co-packer in the health food industry, which serves as the official production partner for the Brain Balls product line and subsequent product lines.
In addition to product and partnership announcements, the NMLSD news feed includes updates on capital markets transactions, such as debt settlement through the issuance of units with share purchase warrants, and the granting of incentive stock options and restricted share units to officers, directors, and consultants. Investors and observers can use this page to review how Restart Life Sciences describes its evolving brand strategy, production arrangements, and related party transactions over time.
Restart Life Sciences Corp (CSE: HEAL, OTC: NMLSD) has secured exclusive licensing rights to four health-related trademarks under a 5-year agreement, renewable for another 5 years. The deal includes a nominal $1 licensing fee and royalty structure of 5% on gross sales up to $1,000,000, reducing to 2.5% for sales exceeding $1,000,000.
The agreement, made with a company controlled by one of Restart Life's directors, includes a previously revenue-generating health-care brand that operated on Amazon. Royalties can be paid in cash, company common shares, or a combination of both. Both parties have agreed to negotiate the purchase of the licensed trademarks at the end of the term.
The transaction is exempt from formal valuation requirements and minority shareholder approval requirements under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions.
Restart Life Sciences Corp. (NMLSD) has secured a strategic production partnership with a Canadian co-packer for manufacturing their Brain Balls product line. The co-packer, known for healthy cereals, will handle raw ingredients, packaging, and shipping from their British Columbia facility.
This partnership follows the December 13, 2024 joint venture with Brain Balls Inc. to develop health-focused products targeting cognitive performance and brain health. The company also completed a debt settlement of $118,476.75 by issuing 1,579,689 units at $0.075 per unit, each including one common share and one warrant exercisable at $0.10 for 12 months.
Additionally, Restart Life granted 1,830,000 stock options and 3,095,000 RSUs to officers, directors, and consultants, exercisable at $0.10 per share with a two-year term.